Mark Gimbel MD
Colon & Rectal Surgery, Melanoma, Surgical Oncology (Other than Breast), Minimally Invasive Surgery
Medical Director TW Lewis Melanoma Center of Excellence Section Lead: Colorectal Surgical Oncology Service Line Adjunct Assistant Professor: UT MD Anderson Cancer Center Assistant Clinical Professor: University of Arizona School of Medicine Phoenix Banner MD Anderson Cancer Center
Join to View Full Profile
2946 E Banner Gateway DrGilbert, AZ 85234
Phone+1 480-256-6444
Fax+1 480-256-4734
Dr. Gimbel is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Mark Gimbel is a Surgical Oncologist at Banner MD Anderson Cancer Center in Gilbert, AZ with subspecialties in melanoma, sarcoma and colon and rectal surgery. He completed his residencies at the University of Florida College of Medicine Jacksonville and the Montefiore Medical Center/Albert Einstein College of Medicine. He then went onto fellowships at the Memorial Sloan Kettering Cancer Center and the H. Lee Moffitt Cancer Center and Research Institute. Dr. Gimbel the Medical Director of the TW Lewis Melanoma Center of Excellence and is an expert in the melanoma field - leading clinical trials and supporting outreach and education. He is also experienced in treating a range of conditions including sarcoma, gastric cancer, gastrointestinal stromal tumors and colorectal cancer. He's contributed significantly to the field through various publications and has been cited numerous times. He has also played a principal role in multiple clinical trials.
Education & Training
H. Lee Moffitt Cancer Center and Research InstituteFellowship, 2007 - 2009
Montefiore Medical Center/Albert Einstein College of MedicineResidency, Surgery, 2004 - 2007
Memorial Sloan Kettering Cancer CenterFellowship, Complex General Surgical Oncology, 2002 - 2004
University of Florida College of Medicine JacksonvilleResidency, Surgery, 2000 - 2002
University of Maryland School of MedicineClass of 2000
Certifications & Licensure
AZ State Medical License 2009 - 2026
FL State Medical License 2008 - 2010
American Board of Surgery Surgery
Awards, Honors, & Recognition
- Fellow (FACS) American College of Surgeons
Clinical Trials
- Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma Start of enrollment: 2019 Dec 17
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- 4 citationsHigh GILT Expression Is Associated with Improved Survival in Metastatic Melanoma Patients Treated with Immune Checkpoint Inhibition.Anngela C Adams, Elizabeth S Borden, Anne M Macy, Nick Thomson, Haiyan Cui
Cancers. 2022-04-28 - 32 citationsThrombotic Thrombocytopenic Purpura due to Checkpoint Inhibitors.Alexey Youssef, Nawara Kasso, Antonio Sergio Torloni, Michael Stanek, Tomislav Dragovich
Case Reports in Hematology. 2018-12-20 - 173 citationsMechanisms of resistance to BRAF and MEK inhibitors and clinical update of US Food and Drug Administration-approved targeted therapy in advanced melanoma.Sunilkumar Kakadia, Naveen Yarlagadda, Ramez Awad, Madappa N. Kundranda, Jiaxin Niu
Oncotargets and Therapy. 2018-10-17
Press Mentions
Health Care Heroes 2022: Physician Winner Dr. Suma RaoAugust 18th, 2022- Phio Pharmaceuticals Announces Addition of Clinical Trial Sites at Banner MD Anderson Cancer Center, the George Washington University, and Integrity ResearchMarch 14th, 2024
Professional Memberships
- Member
- Connective Tissue Oncology SocietyMember
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
